PhRMA adds voice to Rx drug cover debate

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.270, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group

By Gallo Paul  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 275-283

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop

By Krams Michael  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 957-964

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of the “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Lokhnygina Yuliya  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 287-288

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Wassmer Gernot  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 289-291

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of “Executive Summary of the PhRMA Working Group on Adaptive Designs in Clinical Drug Development”

By Jennison Christopher  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 3, 2006-05 ,pp. : 293-298

Taylor & Francis Ltd

Access to resources Recommend Favorite